Detalles de la búsqueda
1.
A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV.
J Virol
; 95(2)2020 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33115876
2.
Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.
J Virol
; 91(15)2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28539444
3.
Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
J Virol
; 90(21): 10022-10038, 2016 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27581977
4.
Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein.
PLoS One
; 19(4): e0301773, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593167
5.
Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques.
J Virol
; 86(2): 1203-13, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22090099
6.
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques.
Nat Med
; 27(12): 2234-2245, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34887575
7.
Nonhuman primates exposed to Zika virus in utero are not protected against reinfection at 1 year postpartum.
Sci Transl Med
; 12(567)2020 10 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33115950
Resultados
1 -
7
de 7
1
Próxima >
>>